The U.S. precision medicine market size was USD 42.68 billion in 2023, calculated at USD 49.79 billion in 2024 and is expected to reach around USD 232.49 billion by 2034, expanding at a CAGR of 16.7% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. U.S. Precision Medicine Market Revenue and Volume, by Technology, 2024-2034
7.1.1. Bioinformatics
7.1.1.1. Market Revenue and Volume Forecast (2021-2034)
7.1.2. Big Data Analytics
7.1.2.1. Market Revenue and Volume Forecast (2021-2034)
7.1.3. Drug Discovery
7.1.3.1. Market Revenue and Volume Forecast (2021-2034)
7.1.4. Gene Sequencing
7.1.4.1. Market Revenue and Volume Forecast (2021-2034)
7.1.5. Companion Diagnostics
7.1.6.1. Market Revenue and Volume Forecast (2021-2034)
7.1.6. Others
7.1.5.1. Market Revenue and Volume Forecast (2021-2034)
8.1. U.S. Precision Medicine Market Revenue and Volume, by Application, 2024-2034
8.1.1. CNS
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Immunology
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Oncology
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Respiratory
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. Others
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
9.1. U.S. Precision Medicine Market Revenue and Volume, by End-Use, 2024-2034
9.1.1. Diagnostic Companies
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Pharmaceutical Companies
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Healthcare IT companies
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
10.1. U.S. Precision Medicine Market Revenue and Volume, by Sequencing Technology, 2024-2034
10.1.1. Sequencing by Synthesis
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Ion Semiconductor Sequencing
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Sequencing by Ligation
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1.4. Pyrosequencing
10.1.4.1. Market Revenue and Volume Forecast (2021-2034)
10.1.5. Single Molecule Real Time Sequencing
10.1.5.1. Market Revenue and Volume Forecast (2021-2034)
10.1.6. Chain Termination Sequencing
10.1.6.1. Market Revenue and Volume Forecast (2021-2034)
10.1.7. Nanopore Sequencing
10.1.7.1. Market Revenue and Volume Forecast (2021-2034)
11.1. U.S. Precision Medicine Market Revenue and Volume, by Product, 2024-2034
11.1.1. Consumables
11.1.1.1. Market Revenue and Volume Forecast (2021-2034)
11.1.2. Instruments
11.1.2.1. Market Revenue and Volume Forecast (2021-2034)
11.1.3. Services
11.1.3.1. Market Revenue and Volume Forecast (2021-2034)
12.1. U.S. Precision Medicine Market Revenue and Volume, by Route of Administration, 2024-2034
12.1.1. Oral
12.1.1.1. Market Revenue and Volume Forecast (2021-2034)
12.1.2. Injectable
12.1.2.1. Market Revenue and Volume Forecast (2021-2034)
13.1. U.S. Precision Medicine Market Revenue and Volume, by Drugs, 2024-2034
13.1.1. Alectinib
13.1.1.1. Market Revenue and Volume Forecast (2021-2034)
13.1.2. Osimertinib
13.1.2.1. Market Revenue and Volume Forecast (2021-2034)
13.1.3. Mepolizumab
13.1.3.1. Market Revenue and Volume Forecast (2021-2034)
13.1.4. Aripiprazole Lauroxil
13.1.4.1. Market Revenue and Volume Forecast (2021-2034)
13.1.5. Others
13.1.5.1. Market Revenue and Volume Forecast (2021-2034)
14.1. U.S.
14.1.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
14.1.2. Market Revenue and Volume Forecast, by Application (2021-2034)
14.1.3. Market Revenue and Volume Forecast, by End-Use (2021-2034)
14.1.4. Market Revenue and Volume Forecast, by Sequencing Technology (2021-2034)
14.1.5. Market Revenue and Volume Forecast, by Product (2021-2034)
14.1.6. Market Revenue and Volume Forecast, by Drugs (2021-2034)
14.1.7. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)
15.1. Biocrates Life Sciences
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Quest Diagnostics
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. NanoString Technologies
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Pfizer
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. AbbVie Inc.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. AstraZeneca
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Johnson & Johnson Services, Inc
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Thermo Fisher Scientific, Inc.
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Illumina, Inc.
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. ARIEL Precision Medicine, Inc.
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample